Amneal Pharmaceuticals Inc. Earnings

Amneal Pharmaceuticals Inc.’s revenue jumped 5.5% since last year same period to $695.42Mn in the Q1 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated -4.8% fall in its revenue since last 3-months.

Amneal Pharmaceuticals Inc.’s net profit jumped 113.31% since last year same period to $12.2Mn in the Q1 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated 139.24% jump in its net profits since last 3-months.

Amneal Pharmaceuticals Inc.’s net profit margin jumped 112.61% since last year same period to 1.75% in the Q1 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated 141.22% jump in its net profit margins since last 3-months.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.17 - a 13.33% jump from last quarter’s estimates.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current year stand at 0.17.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2025. This indicates that the Amneal Pharmaceuticals Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.